Until 1864, when the first British Pharmacopoeia was published, there were no controls over medicines in the UK apart from the Gin Acts of the eighteenth century, which first recognized that government had some responsibility to prevent the adulteration and abuse of a drug. For one hundred years after 1864, however, successive governments were active in laying down standards to ensure the purity and strength of drugs and to prevent their abuse and misdirection. All this was embodied in Dangerous Drugs Acts, Pharmacy and Poisons Acts, Cancer and Venereal Disease Acts and Therapeutic Substances Acts. This mass of legislation was achieved within the context of a bewildering number of statutes in need ofconsolidation, controlled by a variety of organizationssome reporting to the Home Office, others to the Ministry of Health or Agriculture, the Board of Trade or Privy Councilwhich made our legislation on medicines somewhat chaotic. Nevertheless it seemed to work quite well until the explosive introduction of powerful new remedies in the 1940s and 1950s proved it inadequate to cope with modern conditions. Although we had been well aware of the potential danger ofmany of the medicines we were using, we had been curiously complacent about them, and until 1968 no statute in the UK required the premarketing approval of drugs' safety for the purposes for which they were to be used, apart from somne biologicals listed under the Therapeutic Substances Acts. It took the emotional reaction to the thalidomide disaster to galvanize us out of our somewhat laissez faire attitude. Thus, in 1963 the Committee on Safety of Drugs (CSD) was established as a purely voluntary interim expedient until the 1968 Medicines Act could be planned, enacted and become operative. The CSD was official only in the sense that its members were appointed by Ministers of Health who also provided its finance, accommodation and secretariat. It had no legal power and consisted of eleven very part-time, unpaid scientists, physicians and pharmacists, assisted by a small staff of civil servantssix doctors and two pharmacists. The Presidential Address to the Library Section of this Society by Dr E L Harris, published in this number of the Proceedings (p 835), gives an admirably clear and informative account of the various statutory expert advisory committees and sub-committees which, together with the Medicines Commission, were set up under the Medicines Act of 1968 and became operative towards the end of 1971 to advise the Ministers of Health and Agriculture on human and veterinary medicines. Dr Harris' paper deals particularly with the problems of communication encountered by the drug regulatory authority. Just as the number, efficacy and toxicity of drugs have increased in recent decades, so this has been matched in the last few years by a proliferation of the bureaucracy required to control them and to try to ensure a more rational use of medicines both by the prescribing doctor and by the public. Exactly the same thing has occurred in hospital administration. Before the inception of the National Health Service, the largest voluntary general hospital in the UK was controlled by a medical superintendenta retired RAMC Major-Generalwith a secretary and treasurer assisted by a very few clerks and typists. Medicine, of course, has become much more complex since then, but this is matched by the hordes of civil servants and the rash of committees now required to administer the Royal Infirmary of Edinburgh.
Words, hitherto seldom used, may suddenly become popular to convey an idea, though the idea itself may be as old as the hills. Thus a good 'controlled' nutritional experiment is described in the first chapter of the Book of Daniel, and in the eighteenth century James Lind carried out experiments in the Royal Navy on the treatment of scurvy in a remarkably 'controlled' modern fashion. Yet the word 'control' only appeared in medical literature for the first time in 1890 and now it would be difficult to find a medical journal lacking it owing to the work of Sir Austin Bradford Hill. Similarly, though the word 'communicant' has always had a sacramental connotation and though there have been famous exponents of communication from Socrates, Mark Anthony and Paul of Tarsus to Winston Churchill, the words 'communicate' and 'communication' which are used so commonly nowadays were seldom employed until about fifteen years ago.
Proc. roy. Soc. Med. Volume 70 December 1977 One can well understand the formidable problems of communication facing the drug regulatory authority described by Dr Harris. Although information appears to be fundamental to communication, more and better information does not solve the problem; on the contrary, the more the information the greater is the need for effective communication. Thus, in simply providing a mass of informative data the authority does not liquidate its responsibilities, for men hear only what they are capable of hearing. This is what makes communication from above downwards so difficult, unless the communicator knows what the recipient is capable of perceiving, which will be very different in the case of an Oxford don and that of a Beotian labourer. Success demands communication from below upwards as well as above downwards and it may be that drug regulatory authorities do not always take sufficient notice of the opinions of those to whom they attempt to communicate. In this connexion it may be significant to note that Dr Harris starts his address by quoting Dr Charles Fletcher's eight principles of communication but leaves out the last sentence of the eighth aphorism: 'effective communication between colleagues also demands willingness on the part of the giver to discover that more may be learnt than taught'.
Undoubtedly, the presentation of any message must be sufficiently clear and unambiguous for the category of recipient for whom it is intended. Thus, perhaps the biggest problem facing drug regulatory authorities is their relationship with the media, for journalists and broadcasters are experts in communication and they reach individuals in their own homes giving a personal approach.
Dr Charles Fletcher has done more than anyone to encourage communication in medicine, but it is doubtful if he is right when, in his Nuffield Provincial Trust monograph on the subject (Fletcher 1973), he adjures doctors 'to appreciate that journalists and broadcasters are no less responsible than they are themselves and are just as concerned with the good of the public'. It is not denied that the mass media have made outstanding contributions to preventive and therapeutic medicine, but there are very few doctors or scientifically qualified men on editorial staffs and it is doubtful if most journalists are as responsible as most doctors in being concerned with the good of the public. They have to earn their livings by pandering to the public taste for sensationalism, scandal, prurience and anything connected with sexeven the contraceptive pill. Dr Harris gave a very striking example of the harm that can be done when, in his address, he described the leak of information to the press about the cestrogenic content of the pill. Reporters who got hold of this confidential information gave it publicity before the circular had reached doctors, declaring that there was a new risk of the contraceptive pill, rather than the actual discovery of how to reduce an already-known small risk of thromboembolism.
In this area, much might be achieved by drug regulatory authorities if they were to improve their relationship with the media, perhaps by the incorporation of an able press-relations officer taking the media into his confidence. Manifestly it is difficult to establish such a relationship but, in lacking it, communication to the public about drugs is always going to be misunderstood and misinterpreted.
A perusal of Dr Harris' most thought-provoking address impresses one with the fact that democracy is a very difficult form of government. We are all now aware of the disastrous results of the attempt to prohibit alcohol in the USA. In the same way, the apparently very necessary measures to control the prescription, use and production of modern medicines might possibly become the thin edge of the bureaucratic wedge to professional and industrial freedom. The trouble is that, although we nearly all maintain that freedom is good and restriction bad, when someone else's freedom of action becomes inconvenient we usually clamour for its restriction, a restriction which then seems essential in the public interest and based on the purest of motives. 'The Government must do something about it', we say. Such restrictions may be peculiarly undesirable when imposed hysterically to meet a crisis. 
Surgery of Congenital Urinary Tract Disease
In pediatric urology, as in many branches of surgery, there is an increasing scope for the operative correction of disorders of form and function, but also a need for long-term supervision of surgical cases. Most problems relate to congenital urinary tract anomalies, though the surgery of stone and tumour is still of vital importance. Some of the anomalies are familiar from adult urological experience and are readily amenable to standard operative procedures; others are encountered in large numbers only in infancy and require some
